R Saleh
RNA-seq analysis of colorectal tumor-infiltrating myeloid-derived suppressor cell subsets revealed gene signatures of poor prognosis
Saleh, R; Sasidharan Nair, V; Al-Dhaheri, M; Khawar, M; Abu Nada, M; Alajez, NM; Elkord, E
Authors
V Sasidharan Nair
M Al-Dhaheri
M Khawar
M Abu Nada
NM Alajez
E Elkord
Contributors
GS Karagiannis
Editor
ZS Guo
Other
T Alban
Other
Abstract
Elevated levels of myeloid-derived suppressor cells (MDSCs), including polymorphonuclear MDSCs (PMN-MDSCs) and immature MDSCs (I-MDSCs), are usually associated with disease progression in cancer patients, including colorectal cancer (CRC). However, biological mechanisms and molecular pathways regulated by MDSC subpopulations in the CRC tumor microenvironment (TME) have not been fully investigated. In this study, we performed transcriptomic analysis of tumor-infiltrating I-MDSCs and PMN-MDSCs isolated from tumor tissues of six CRC patients, compared to antigen-presenting cells (APCs). We also compared the transcriptomic profiles of tumor-infiltrating PMN-MDSCs to I-MDSCs. Our results showed different molecular pathways regulated by each MDSC subset, potentially reflecting their phenotypical/molecular/functional characteristics in the CRC TME. Moreover, we identified gene signatures in PMN-MDSC and I-MDSC of poor overall survival (OS) and disease-free survival (DFS) using the Cancer Genome Atlas (TCGA) dataset from patients with colon adenocarcinoma (COAD). However, functional studies are required to validate these findings.
Citation
Saleh, R., Sasidharan Nair, V., Al-Dhaheri, M., Khawar, M., Abu Nada, M., Alajez, N., & Elkord, E. (2020). RNA-seq analysis of colorectal tumor-infiltrating myeloid-derived suppressor cell subsets revealed gene signatures of poor prognosis. Frontiers in Oncology, 10, 604906. https://doi.org/10.3389/fonc.2020.604906
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 15, 2020 |
Online Publication Date | Nov 10, 2020 |
Publication Date | Nov 10, 2020 |
Deposit Date | Dec 1, 2020 |
Publicly Available Date | Dec 1, 2020 |
Journal | Frontiers in Oncology |
Publisher | Frontiers Media |
Volume | 10 |
Pages | 604906 |
DOI | https://doi.org/10.3389/fonc.2020.604906 |
Publisher URL | https://doi.org/10.3389/fonc.2020.604906 |
Related Public URLs | https://www.frontiersin.org/journals/451 |
Additional Information | Additional Information : ** From Frontiers via Jisc Publications Router ** Licence for this article: http://creativecommons.org/licenses/by/4.0/ **Journal IDs: eissn 2234-943X **History: published_online 10-11-2020; accepted 15-10-2020; submitted 10-09-2020; collection 2020 Funders : Qatar Biomedical Research Institute, Qatar Foundation Grant Number: VR04 |
Files
fonc-10-604906.pdf
(2.8 Mb)
PDF
Licence
http://creativecommons.org/licenses/by/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Downloadable Citations
About USIR
Administrator e-mail: library-research@salford.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search